Lu Xiangyi’s 50-unit TD5 multi-tube rack centrifuge boosts the efficient development of Jiangsu Yuanwen Biotechnology.
Detailed introduction
— Safeguarding industrial upgrading with innovative technologies
Recently, Shanghai Luxiangyi Centrifuge Instrument Co., Ltd. (hereinafter referred to as “Luxiangyi”) officially delivered 50 TD5 multi-tube rack automatic balancing centrifuges to Jiangsu Yuanwen Technology Co., Ltd. (hereinafter referred to as “Jiangsu Yuanwen”). This collaboration marks a deep alignment between Luxiangyi’s R&D capabilities in the centrifuge field and Jiangsu Yuanwen’s strategic needs in the biotechnology sector, injecting new momentum into the industry’s high-quality development.
Precisely matching customer needs, the TD5 low-speed multi-tube rack centrifuge showcases its robust strength.
As a leading enterprise in the biopharmaceutical sector in East China, Jiangsu Yuanwen has long been focused on high-precision processes such as drug development and separation and purification of biological products, placing extremely high demands on the stability, processing efficiency, and intelligent level of centrifugal equipment. The Lu Xiangyi TD5 series centrifuge stands out thanks to the following core advantages:
Fully automatic balancing technology: Utilizing intelligent sensors to detect rotor load in real time and automatically adjusting balancing parameters, this technology eliminates human calibration errors and ensures safety and separation accuracy even at high speeds.
Flexible multi-tube rack adaptation: Supports quick switching between various tube rack specifications, meeting the large-scale drug screening and high-throughput experimental needs of Jiangsu Yuanwen.
Intelligent Control System: Utilizing PLC programming and variable-frequency speed control technology, this system achieves precise control of parameters such as rotational speed, temperature, and time. It complies with GMP standards in the pharmaceutical industry and ensures process traceability.
Empower scenarios with technology and drive the upgrading of the biopharmaceutical industry.
As the “precision heart” of the biopharmaceutical industry chain, the performance of centrifuges directly affects R&D efficiency and product quality. The Lu Xiangyi TD5 series excels in applications such as drug synthesis and purification, as well as cell separation. Its low-noise design and energy-saving mode significantly reduce laboratory operating costs.
The 50 units delivered this time will be primarily used for:
Biopharmaceutical field: Gradient centrifugation and impurity separation for biological products such as vaccines and antibody proteins;
Precision medicine R&D: Pre-processing of gene sequencing samples and high-purity extraction of cellular components;
Environmental Monitoring: Solid-Liquid Separation and Pollutant Detection in Water Quality Analysis.
China’s domestically produced intelligent manufacturing is on the rise, and Lu Xiangyi is deeply committed to driving innovation in her industry.
Lu Xiangyi has consistently adhered to the quality principle of “quality first, reputation paramount,” leveraging its own intellectual property rights to break through the industry bottleneck of relying on imported high-end centrifuges. The delivery of the TD5 series not only reflects Jiangsu Yuanwen’s trust in the Lu Xiangyi brand but also marks a landmark breakthrough for domestically produced centrifuge equipment in the biotechnology sector. Looking ahead, the two parties will engage in deepened cooperation centered on the construction of intelligent laboratories and customized centrifuge solutions, jointly driving the upgrading of industry standards.
About Lu Xiangyi
Shanghai Luxiangyi Centrifuge Instrument Co., Ltd. has been dedicated to the R&D and manufacturing of centrifuges for 40 years. Its product portfolio covers three major sectors—medical, scientific research, and industrial—and its service network spans the entire country. The TD5 series, as its flagship product, will earn a strong market reputation thanks to its outstanding performance.